These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 23395662

  • 1. Synthesis of tartaric acid analogues of FR258900 and their evaluation as glycogen phosphorylase inhibitors.
    Varga G, Docsa T, Gergely P, Juhász L, Somsák L.
    Bioorg Med Chem Lett; 2013 Mar 15; 23(6):1789-92. PubMed ID: 23395662
    [Abstract] [Full Text] [Related]

  • 2. FR258900, a potential anti-hyperglycemic drug, binds at the allosteric site of glycogen phosphorylase.
    Tiraidis C, Alexacou KM, Zographos SE, Leonidas DD, Gimisis T, Oikonomakos NG.
    Protein Sci; 2007 Aug 15; 16(8):1773-82. PubMed ID: 17600143
    [Abstract] [Full Text] [Related]

  • 3. The binding of β-d-glucopyranosyl-thiosemicarbazone derivatives to glycogen phosphorylase: A new class of inhibitors.
    Alexacou KM, Tenchiu Deleanu AC, Chrysina ED, Charavgi MD, Kostas ID, Zographos SE, Oikonomakos NG, Leonidas DD.
    Bioorg Med Chem; 2010 Nov 15; 18(22):7911-22. PubMed ID: 20947361
    [Abstract] [Full Text] [Related]

  • 4. Synthesis of 2-(β-D-glucopyranosylamino)-5-substituted-1,3,4-oxadiazoles for inhibition of glycogen phosphorylase.
    Tóth M, Szőcs B, Kaszás T, Docsa T, Gergely P, Somsák L.
    Carbohydr Res; 2013 Nov 15; 381():196-204. PubMed ID: 23673237
    [Abstract] [Full Text] [Related]

  • 5. Discovery of novel dual-action antidiabetic agents that inhibit glycogen phosphorylase and activate glucokinase.
    Zhang L, Chen X, Liu J, Zhu Q, Leng Y, Luo X, Jiang H, Liu H.
    Eur J Med Chem; 2012 Dec 15; 58():624-39. PubMed ID: 23178962
    [Abstract] [Full Text] [Related]

  • 6. Identification, synthesis, and characterization of new glycogen phosphorylase inhibitors binding to the allosteric AMP site.
    Kristiansen M, Andersen B, Iversen LF, Westergaard N.
    J Med Chem; 2004 Jul 01; 47(14):3537-45. PubMed ID: 15214781
    [Abstract] [Full Text] [Related]

  • 7. Synthesis of N-(beta-D-glucopyranosyl) monoamides of dicarboxylic acids as potential inhibitors of glycogen phosphorylase.
    Czifrák K, Hadady Z, Docsa T, Gergely P, Schmidt J, Wessjohann L, Somsák L.
    Carbohydr Res; 2006 Jun 12; 341(8):947-56. PubMed ID: 16564511
    [Abstract] [Full Text] [Related]

  • 8. Synthesis of substituted 2-(β-D-glucopyranosyl)-benzimidazoles and their evaluation as inhibitors of glycogen phosphorylase.
    Bokor É, Szilágyi E, Docsa T, Gergely P, Somsák L.
    Carbohydr Res; 2013 Nov 15; 381():179-86. PubMed ID: 23419607
    [Abstract] [Full Text] [Related]

  • 9. Glucopyranosylidene-spiro-iminothiazolidinone, a new bicyclic ring system: synthesis, derivatization, and evaluation for inhibition of glycogen phosphorylase by enzyme kinetic and crystallographic methods.
    Czifrák K, Páhi A, Deák S, Kiss-Szikszai A, Kövér KE, Docsa T, Gergely P, Alexacou KM, Papakonstantinou M, Leonidas DD, Zographos SE, Chrysina ED, Somsák L.
    Bioorg Med Chem; 2014 Aug 01; 22(15):4028-41. PubMed ID: 25009003
    [Abstract] [Full Text] [Related]

  • 10. Synthesis of N-(beta-D-glucopyranosyl)- and N-(2-acetamido-2-deoxy-beta-D-glucopyranosyl) amides as inhibitors of glycogen phosphorylase.
    Györgydeák Z, Hadady Z, Felföldi N, Krakomperger A, Nagy V, Tóth M, Brunyánszki A, Docsa T, Gergely P, Somsák L.
    Bioorg Med Chem; 2004 Sep 15; 12(18):4861-70. PubMed ID: 15336265
    [Abstract] [Full Text] [Related]

  • 11. Natural flavonoids as antidiabetic agents. The binding of gallic and ellagic acids to glycogen phosphorylase b.
    Kyriakis E, Stravodimos GA, Kantsadi AL, Chatzileontiadou DS, Skamnaki VT, Leonidas DD.
    FEBS Lett; 2015 Jul 08; 589(15):1787-94. PubMed ID: 25980608
    [Abstract] [Full Text] [Related]

  • 12. Glutathione-dependent reduction of arsenate by glycogen phosphorylase responsiveness to endogenous and xenobiotic inhibitors.
    Gregus Z, Németi B.
    Toxicol Sci; 2007 Nov 08; 100(1):44-53. PubMed ID: 17693424
    [Abstract] [Full Text] [Related]

  • 13. N-(4-Substituted-benzoyl)-N'-(β-d-glucopyranosyl)ureas as inhibitors of glycogen phosphorylase: Synthesis and evaluation by kinetic, crystallographic, and molecular modelling methods.
    Nagy V, Felföldi N, Kónya B, Praly JP, Docsa T, Gergely P, Chrysina ED, Tiraidis C, Kosmopoulou MN, Alexacou KM, Konstantakaki M, Leonidas DD, Zographos SE, Oikonomakos NG, Kozmon S, Tvaroška I, Somsák L.
    Bioorg Med Chem; 2012 Mar 01; 20(5):1801-16. PubMed ID: 22325154
    [Abstract] [Full Text] [Related]

  • 14. Crystallographic studies on acyl ureas, a new class of glycogen phosphorylase inhibitors, as potential antidiabetic drugs.
    Oikonomakos NG, Kosmopoulou MN, Chrysina ED, Leonidas DD, Kostas ID, Wendt KU, Klabunde T, Defossa E.
    Protein Sci; 2005 Jul 01; 14(7):1760-71. PubMed ID: 15987904
    [Abstract] [Full Text] [Related]

  • 15. C-Glucosylated malonitrile as a key intermediate towards carbohydrate-based glycogen phosphorylase inhibitors.
    Feuillastre S, Chajistamatiou AS, Potamitis C, Zervou M, Zoumpoulakis P, Chrysina ED, Praly JP, Vidal S.
    Bioorg Med Chem; 2012 Sep 15; 20(18):5592-9. PubMed ID: 22910227
    [Abstract] [Full Text] [Related]

  • 16. Synthesis of C-xylopyranosyl- and xylopyranosylidene-spiro-heterocycles as potential inhibitors of glycogen phosphorylase.
    Somsák L, Bokor É, Czibere B, Czifrák K, Koppány C, Kulcsár L, Kun S, Szilágyi E, Tóth M, Docsa T, Gergely P.
    Carbohydr Res; 2014 Nov 18; 399():38-48. PubMed ID: 25081322
    [Abstract] [Full Text] [Related]

  • 17. Binding of oxalyl derivatives of beta-d-glucopyranosylamine to muscle glycogen phosphorylase b.
    Hadjiloi T, Tiraidis C, Chrysina ED, Leonidas DD, Oikonomakos NG, Tsipos P, Gimisis T.
    Bioorg Med Chem; 2006 Jun 01; 14(11):3872-82. PubMed ID: 16464598
    [Abstract] [Full Text] [Related]

  • 18. Pentacyclic triterpenes. Part 2: Synthesis and biological evaluation of maslinic acid derivatives as glycogen phosphorylase inhibitors.
    Wen X, Zhang P, Liu J, Zhang L, Wu X, Ni P, Sun H.
    Bioorg Med Chem Lett; 2006 Feb 01; 16(3):722-6. PubMed ID: 16246555
    [Abstract] [Full Text] [Related]

  • 19. Modeling aided design of potent glycogen phosphorylase inhibitors.
    Deng Q, Lu Z, Bohn J, Ellsworth KP, Myers RW, Geissler WM, Harris G, Willoughby CA, Chapman K, McKeever B, Mosley R.
    J Mol Graph Model; 2005 Apr 01; 23(5):457-64. PubMed ID: 15781188
    [Abstract] [Full Text] [Related]

  • 20. Identification of pentacyclic triterpenes derivatives as potent inhibitors against glycogen phosphorylase based on 3D-QSAR studies.
    Liang Z, Zhang L, Li L, Liu J, Li H, Zhang L, Chen L, Cheng K, Zheng M, Wen X, Zhang P, Hao J, Gong Y, Zhang X, Zhu X, Chen J, Liu H, Jiang H, Luo C, Sun H.
    Eur J Med Chem; 2011 Jun 01; 46(6):2011-21. PubMed ID: 21439694
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.